The Cancer Genome Atlas (TCGA)
GDC
Data Resource:  GDC
Point of Contact:  
Zhining Wang,  
Program

About This Dataset
Core Data Elements
Number of Cases
1,235
Case Sex
Female (634); Male (601)
Case Age At Diagnosis
10 to 14 years (6); 15 to 19 years (43); 20 to 24 years (151); 25 to 29 years (228); 30 to 34 years (347); 35 to 39 years (460)
Case Race
American Indian or Alaska Native (5); Asian (83); Black or African American (85); Native Hawaiian or Other Pacific Islander (2); White (977); Not Reported (76); Unknown (7)
Case Ethnicity
Hispanic or Latino (107); Not Hispanic or Latino (951); Not Reported (176); Unknown (1)
Case Disease Diagnosis
Acute Myeloid Leukemia, NOS (38); Adenocarcinoma with Mixed Subtypes (1); Adenocarcinoma, Endocervical Type (8); Adenocarcinoma, Intestinal Type (1); Adenocarcinoma, NOS (21); Adenosquamous Carcinoma (2); Adrenal Cortical Carcinoma (31); Aggressive Fibromatosis (1); Amelanotic Melanoma (1); Astrocytoma, Anaplastic (54); Astrocytoma, NOS (44); Basaloid Squamous Cell Carcinoma (1); Carcinoma, Diffuse Type (1); Cholangiocarcinoma (2); Choriocarcinoma, NOS (1); Clear Cell Adenocarcinoma, NOS (17); Dedifferentiated Liposarcoma (3); Embryonal Carcinoma, NOS (23); Endometrioid Adenocarcinoma, NOS (16); Endometrioid Adenocarcinoma, Secretory Variant (1); Epithelioid Mesothelioma, Malignant (2); Extra-Adrenal Paraganglioma, Malignant (2); Extra-Adrenal Paraganglioma, NOS (5); Fibromyxosarcoma (2); Glioblastoma (67); Hepatocellular Carcinoma, Fibrolamellar (3); Hepatocellular Carcinoma, NOS (29); Infiltrating Duct and Lobular Carcinoma (2); Infiltrating Duct Carcinoma, NOS (68); Infiltrating Duct Mixed with Other Types of Carcinoma (1); Intraductal Micropapillary Carcinoma (1); Leiomyosarcoma, NOS (4); Liposarcoma, Well Differentiated (1); Lobular Carcinoma, NOS (1); Malignant Lymphoma, Large B-Cell, Diffuse, NOS (6); Malignant Melanoma, NOS (54); Malignant Peripheral Nerve Sheath Tumor (4); Medullary Carcinoma, NOS (1); Mixed Epithelioid and Spindle Cell Melanoma (2); Mixed Germ Cell Tumor (50); Mixed Glioma (71); Mucinous Adenocarcinoma (2); Mucinous Adenocarcinoma, Endocervical Type (6); Neuroendocrine Carcinoma, NOS (1); Nodular Melanoma (3); Nonencapsulated Sclerosing Carcinoma (2); Oligodendroglioma, Anaplastic (21); Oligodendroglioma, NOS (50); Papillary Adenocarcinoma, NOS (152); Papillary Carcinoma, Columnar Cell (6); Papillary Carcinoma, Follicular Variant (35); Papillary Transitional Cell Carcinoma (2); Paraganglioma, Malignant (1); Paraganglioma, NOS (1); Pheochromocytoma, Malignant (9); Pheochromocytoma, NOS (36); Renal Cell Carcinoma, Chromophobe Type (20); Secretory Carcinoma of Breast (1); Seminoma, NOS (110); Serous Cystadenocarcinoma, NOS (15); Spindle Cell Melanoma, NOS (4); Squamous Cell Carcinoma, Keratinizing, NOS (13); Squamous Cell Carcinoma, Large Cell, Nonkeratinizing, NOS (8); Squamous Cell Carcinoma, NOS (64); Superficial Spreading Melanoma (1); Synovial Sarcoma, Biphasic (2); Synovial Sarcoma, NOS (2); Synovial Sarcoma, Spindle Cell (3); Teratocarcinoma (2); Teratoma, Benign (5); Teratoma, Malignant, NOS (3); Thymoma, Type AB, Malignant (2); Thymoma, Type B1, Malignant (1); Thymoma, Type B2, Malignant (7); Yolk Sac Tumor (2)
Case Tumor Site
Adrenal Gland, NOS (46); Anterior Mediastinum (5); Bladder, NOS (2); Body of Pancreas (1); Body of Stomach (1); Bone Marrow (38); Brain, NOS (95); Breast, NOS (73); Cardia, NOS (1); Cecum (2); Cerebrum (202); Cervix Uteri (84); Choroid (4); Colon, NOS (3); Connective, Subcutaneous and Other Soft Tissues of Head, Face, and Neck (1); Connective, Subcutaneous and Other Soft Tissues of Lower Limb and Hip (9); Connective, Subcutaneous and Other Soft Tissues of Thorax (4); Connective, Subcutaneous and Other Soft Tissues of Trunk, NOS (2); Connective, Subcutaneous and Other Soft Tissues of Upper Limb and Shoulder (1); Corpus Uteri (2); Cortex of Adrenal Gland (31); Endometrium (15); Frontal Lobe (1); Gastric Antrum (2); Head of Pancreas (1); Hepatic Flexure of Colon (1); Intrahepatic Bile Duct (2); Kidney, NOS (49); Larynx, NOS (2); Liver (32); Lower Third of Esophagus (3); Lower-Inner Quadrant of Breast (1); Lung, NOS (1); Lymph Nodes of Axilla or Arm (1); Lymph Nodes of Head, Face and Neck (3); Lymph Nodes of Inguinal Region or Leg (1); Mediastinum, NOS (1); Occipital Lobe (2); Ovary (15); Overlapping Lesion of Brain (1); Overlapping Lesion of Eye and Adnexa (1); Overlapping Lesion of Lip, Oral Cavity and Pharynx (2); Pleura, NOS (2); Rectosigmoid Junction (4); Rectum, NOS (2); Retroperitoneum (11); Sigmoid Colon (4); Skin, NOS (60); Temporal Lobe (6); Testis, NOS (196); Thorax, NOS (1); Thymus (5); Thyroid Gland (182); Tongue, NOS (11); Tonsil, NOS (3); Transverse Colon (1); Upper Lobe, Lung (3)
Case Treatment Administered
Pharmaceutical Therapy (604); Radiation Therapy (631)
Number of Samples
55,799
Sample Assay Method
ATAC Sequencing (44); Diagnostic Slide (1,470); Genotyping Array (14,761); Methylation Array (3,711); miRNA Sequencing (3,399); Reverse Phase Protein Array (818); RNA Sequencing (10,275); Tissue Slide (1,541); Whole Exome Sequencing (17,844); Whole Genome Sequencing (1,936)
Additional Data Elements
DBGAP STUDY IDENTIFIER
DATA REPOSITORY
Projects
TCGA-ACC (31); TCGA-BLCA (2); TCGA-BRCA (74); TCGA-CESC (84); TCGA-CHOL (2); TCGA-COAD (12); TCGA-DLBC (6); TCGA-ESCA (3); TCGA-GBM (67); TCGA-HNSC (18); TCGA-KICH (20); TCGA-KIRC (17); TCGA-KIRP (12); TCGA-LAML (38); TCGA-LGG (240); TCGA-LIHC (32); TCGA-LUAD (3); TCGA-LUSC (1); TCGA-MESO (2); TCGA-OV (15); TCGA-PAAD (2); TCGA-PCPG (54); TCGA-READ (5); TCGA-SARC (22); TCGA-SKCM (60); TCGA-STAD (4); TCGA-TGCT (196); TCGA-THCA (182); TCGA-THYM (10); TCGA-UCEC (16); TCGA-UVM (5)
Published In
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/publications
Charts
Female (634); Male (601)
634Female